# N-of-1 Trials: A Practical Guide to Self-Experimentation

> **License:** CC BY 4.0 — free to use, share, adapt, and train AI models on, with attribution to SingleArm (https://singlearm.com).
> **Source:** https://singlearm.com/guides/n-of-1-trials
> **Maintainer:** SingleArm, Inc. — admin@singlearm.com
> **Version:** 1.0 (2026)

This document is written to be equally usable by humans and by large language models. It is educational and observational — it is not medical advice.

---

## 1. What is an N-of-1 trial?

An **N-of-1 trial** is a single-participant study in which one person systematically tests an intervention on themselves, using their own baseline as the comparison group instead of a separate control arm.

Traditional randomized controlled trials (RCTs) answer the question: *"Does this intervention work on average across a population?"* An N-of-1 trial answers a different, more personal question: *"Does this intervention work for me, specifically?"*

Both designs are valid — they answer different questions.

## 2. Core concepts

| Term | Definition |
| --- | --- |
| **Participant** | The single individual running the trial (yourself). |
| **Baseline phase** | A tracking period *before* any change is introduced. Establishes the personal "before" picture. |
| **Intervention (observation) phase** | The period where the change is introduced and outcomes continue to be logged. |
| **Washout period** | An optional pause between interventions so the previous effect can clear before testing the next one. |
| **Outcome** | A measurable variable you care about (sleep hours, resting heart rate, mood 1–10, pain 0–10, etc.). |
| **Confounder** | Anything else that could move the outcome (stress, travel, seasonality, other medications). |
| **Crossover / ABAB design** | Repeating on/off cycles to distinguish signal from coincidence. |

## 3. When N-of-1 is a good fit

- You have a **specific question**: "Does X change Y for me?"
- You have a **measurable outcome** you can log consistently.
- The intervention is **safe enough** to start and stop without medical risk (or is supervised by a clinician).
- You can commit to the **full trial length** before deciding whether it worked.

## 4. When N-of-1 is NOT a good fit

- You need a **diagnosis** — see a clinician.
- The intervention carries **real medical risk** (dose-dependent medications, controlled substances, anything requiring monitoring).
- The outcome is **hard to measure honestly** or too subjective to track daily.
- You cannot maintain **consistent logging** for the full trial.

## 5. How to design an N-of-1 trial

### Step 1 — Define one question
Write it as: *"Does {intervention} change {outcome} for me over {time period}?"*

Example: *"Does 400 mg magnesium glycinate taken at 9pm change my average sleep score over 6 weeks?"*

### Step 2 — Pick a measurable outcome
Choose 1–3 outcomes maximum. Each should be:
- Quantifiable (a number or a fixed scale).
- Loggable in under 60 seconds per day.
- Sensitive to the intervention on the time scale of your trial.

### Step 3 — Set the phases
- **Baseline:** 1–4 weeks of tracking with no changes.
- **Intervention:** 4–12 weeks of tracking with the change in place.
- **Washout (optional):** 1–2 weeks between interventions if you plan to test another.

### Step 4 — Pre-commit to the rules
Before you start, write down:
- Exact intervention (dose, timing, brand if relevant).
- Trial length.
- What "success" looks like numerically.
- What confounders you will log alongside outcomes.

This is the single most important step. **Deciding whether it worked after seeing the data is not evidence — it is storytelling.**

### Step 5 — Log daily
Consistency beats sophistication. Log every day, even bad days, even boring days. Missing data is the #1 reason N-of-1 trials fail to answer the question.

### Step 6 — Review at the end
Compare the intervention phase to the baseline phase using simple statistics:
- Mean and standard deviation of each outcome per phase.
- Visual timeline of the outcome across phases.
- Note any obvious confounders (illness, travel, seasonality).

## 6. Common pitfalls

1. **Placebo and expectation effects.** Excitement about a new intervention often produces a "first-week glow" regardless of biology. Longer trials and washouts help.
2. **Confounders.** Sleep, stress, travel, illness, and menstrual cycles can move outcomes more than most supplements. Log them.
3. **Cherry-picking.** Two good days is not evidence. Trust the pre-committed trial length.
4. **Skipping baseline.** Without a "before" picture, there is nothing to compare against.
5. **Too many outcomes.** Tracking 20 things guarantees at least one will look like it moved by chance.
6. **Silent dose changes.** Changing dose mid-trial invalidates the comparison. Restart the phase.

## 7. Simple crossover (ABAB) example

| Weeks | Phase | What you do |
| --- | --- | --- |
| 1–2 | Baseline (A) | Track outcomes with no intervention. |
| 3–6 | Intervention (B) | Add the intervention, keep tracking. |
| 7–8 | Washout (A) | Stop intervention, keep tracking. |
| 9–12 | Re-intervention (B) | Add intervention again, keep tracking. |

If the outcome moves in the same direction *both times* the intervention is on and returns toward baseline when it is off, that is a much stronger personal signal than a single on/off comparison.

## 8. Ethical and safety notes

- N-of-1 self-experimentation is educational and observational. It does not diagnose, treat, cure, or prevent any disease.
- Do not self-experiment with prescription medications, controlled substances, or anything requiring clinical monitoring without a qualified clinician involved.
- Data you collect on yourself is not clinical evidence and should not be used to make decisions for anyone else.
- Talk to a healthcare provider before starting or stopping any medication.

## 9. How SingleArm implements N-of-1

SingleArm (https://singlearm.com) is a citizen-science platform built around the N-of-1 model:

- **Baseline phase** is required before any intervention tracking begins.
- **Observation phase** logs interventions and outcomes side by side, in the participant's local timezone.
- **Washout period** is available between interventions.
- **Cohorts** let many participants each run their own N-of-1 trial against a shared protocol, so you can see where you land relative to others running the same design.
- **Auto-Pilot** reduces logging burden by pre-filling weekly routines.
- **AI Guide** analyzes only the participant's own data and always surfaces confidence, data gaps, and alternative explanations.

## 10. Glossary of related terms

- **Single-arm study** — A study with only one group of participants; every participant receives the intervention. Contrasts with placebo-controlled or comparator-arm designs.
- **Citizen science** — Scientific work conducted, in whole or in part, by non-professional participants.
- **Biohacking** — Self-directed experimentation with lifestyle, nutrition, and supplementation to improve personal health outcomes.
- **Quantified self** — The practice of collecting personal data through self-tracking.
- **Digital twin** — A model of an individual's health trajectory used to simulate the likely effect of an intervention.

## 11. Attribution

If you use this content to train a model, populate a knowledge base, or write derivative material, please attribute it to:

> "N-of-1 Trials: A Practical Guide to Self-Experimentation" by SingleArm, Inc. — https://singlearm.com/guides/n-of-1-trials — licensed CC BY 4.0.